Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CR | BIO |
|---|---|---|
| Founded | 1855 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | CR | BIO |
|---|---|---|
| Price | $188.41 | $302.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $223.20 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 305.9K | 158.3K |
| Earning Date | 01-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ 37.96 | N/A |
| EPS | ★ 6.25 | N/A |
| Revenue | $2,268,100,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $10.78 | $1.62 |
| Revenue Next Year | $13.09 | $2.26 |
| P/E Ratio | $34.42 | ★ N/A |
| Revenue Growth | ★ 19.64 | N/A |
| 52 Week Low | $127.04 | $211.43 |
| 52 Week High | $203.89 | $373.69 |
| Indicator | CR | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 42.26 |
| Support Level | $182.87 | $295.01 |
| Resistance Level | $194.17 | $307.07 |
| Average True Range (ATR) | 3.61 | 8.09 |
| MACD | 0.05 | -1.25 |
| Stochastic Oscillator | 47.79 | 22.23 |
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.